Outcome of Injection Sclerotherapy With Doxycycline in Lymphatic, and Veno-lymphatic Malformation in Children: A Single Centre Experience

In brief

This study evaluates doxycycline sclerotherapy outcomes for treating congenital lymphatic and veno-lymphatic malformations in pediatric patients at a single institution. The research examines intralesional sclerotherapy as an alternative treatment approach for these slow-flow vascular anomalies in children.

• Doxycycline sclerotherapy is an effective alternative treatment for lymphatic and veno-lymphatic malformations in pediatric patients.
• Intralesional sclerotherapy targets congenital slow-flow vascular malformations without requiring surgical excision.
• Single-center experience demonstrates feasibility of doxycycline as a sclerosing agent for LMs and VLMs in children.
• Treatment approach offers minimally invasive option for managing complex pediatric vascular anomalies.

Written by the GCMD Library team from the article.